chrisvoncsefalvay/vaers-outcomes huggingface dataset:
patient got the flu two years in a row while taking the shot.; Initial information received on 15-Nov-2020 regarding an unsolicited non-valid non-serious social media case received from a consumer.   This case involves a patient who got the flu two years in a row while taking the shot (influenza), while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.   Concomitant medications were unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient got the flu two years in a row while taking the shot (influenza) (Unknown latency) following the administration of INFLUENZA VACCINE.  Relevant laboratory data was not reported.   It was not reported if the patient received a corrective treatment.  The patient outcome is reported as Unknown.  There will be no information available on the batch number for this case.
pt exp chills & fever lasting 2 days p/Typhoid vax; in addition, pt devel edema & stiffness of the injected arm;
Pt. with known allergic type reaction after first dose of vaccine, discussed getting the 2nd vaccine by intensivist and pulmonologist and was advised to go ahead and get second vaccine.  1st vaccine Reaction: Itchiness of entire body, fatigue, tongue "felt funny,"  stomach cramping.    She was premedicated with Prednisone 40 mg po, Benadryl 25 mg po, Pepcid 20 mg morning of vaccine.  Pt. was administered vaccine at 12:15 am and at 12:40, she started to have tongue and throat itching, swelling, voice change, H/A and abd. pain. Medical first response was called and Dr. (Anesthesia) and FNP was present on-site at 12:41 Epi 0.3 mg sq was given.  Additional 50 mg IM of Benadryl was also administered.  Pt. was transported to ED via wheelchair and found to have angioedema and dx of anaphylaxis.   Pt. was administered Benadryl IV, Pepcid IV, Solu-Medrol IV, Epi IV was administered in the ED due to persistent angioedema.  She was discharge home same day at 16:03 and asked to f/u with PCP in1-3 days.   2/2/21- Still on prednisone, pepcid and Zrytec.  Tongue still feels itchy and a little swollen, but overall feeling well.
Injection in left deltoid. Pain in left arm. Large lump at injection site, red and tender to touch. Pt stated that throat "my throat feels funny." Benadryl 50 mg IV in ED and sent home with Benadryl. RX: Take 50 mg by mouth every four hours if needed.
I had vaccination on 09/2022. In 10/2022 I got a sinus infection and had congestion. The sinus infection lasted through 01/2023. I was on antibiotics for a month and had a referral to a specialist.
Déveloped low grade fever for ten days accompanied by painful posterior cervical spine with posterior cervical lymphadenopathy. Had pressure in the TMJ?s. After 3 and a half weeks my right  kneee swelled and I had a hard time weight bearing and couldn?t walk.  My  posterior cervical spine and right shoulder developped pain
Headaches; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headaches) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headaches). At the time of the report, HEADACHE (Headaches) outcome was unknown.           AE submitted. Patient had a query of how to get rid of headache after vaccination. Patient Used Tylenol but it's not helping.
I had started noticing some issues with my left eye on about 11/23/2022. I wasn't seeing as well out of my left eye, and I noticed that whenever I looked at things, my vision in my left eye seemed darker than that in the right eye. And whenever I closed my eyes, I could see little shapes in the left eye. On 11/27/2022, when I woke up, I couldn't see much out of the left eye, so I called my ophthalmologist and went to see him that same day for an emergency visit. He said that I had a bleed in the left eye, and he referred me to a retina specialist, whom I saw the first week in December 2022. The retina specialist informed me that I had a "massive bleed" in the left eye and injected EYLEA in the left eye on 1/5/2023. On 1/6/2023, he injected a gas bubble in the left eye. I had to hold my head down for nine days afterwards, which wasn't easy. I received another EYLEA injection on 2/9/2023, and I am scheduled for another EYLEA injection in March 2023. At the time of this writing, I think that my vision is improving to some degree. The dark spot in my left is now smaller, and I can see the eye chart better whenever I go to the eye doctor. During the December 2022 visit, the ophthalmologist advised me to begin taking PRESERVISION supplements, which I have done. On 2/19/2023, I woke up and felt awful. I had a horrible headache, a cough, a little bit of congestion, and a horrible fatigue. I decided to go to urgent care. I was tested for COVID-19, and the result was positive. The urgent care prescribed LAGEVRIO. I felt somewhat better within a couple of days of starting. The cough went away. I still have the residual fatigue. I had a couple of days in which I had a headache, a couple of days in which I had nausea. I also had the chills for quite a few days. During my time with COVID-19, I seemed to roll through all the symptoms that are listed by the CDC, except I didn't lose my senses of taste and smell. The fatigue was pervasive and persistent, though. Whenever I would perform simple tasks, I would have to stop and rest for a while. I consulted with my GP, and he told me that I needed to move as much as possible and not succumb to the fatigue. I had to force myself to move, but I think it helped me feel better. I also kept an eye on my oxygen levels, and they were always within normal range. The COVID-19 was at its worst for three days, but it got better afterwards, though I still wasn't completely over it. At this point, the fatigue persists and I still get the chills, but otherwise I feel fine.
Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 12-JUL-2022; Administered the vaccine to 346 patients after the 30 day by used; Patient administered the vaccine after the 30 days by used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 12-JUL-2022) and NO ADVERSE EVENT (Administered the vaccine to 346 patients after the 30 day by used) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 12-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 12-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 12-JUL-2022) and NO ADVERSE EVENT (Administered the vaccine to 346 patients after the 30 day by used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used), PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 12-JUL-2022) and NO ADVERSE EVENT (Administered the vaccine to 346 patients after the 30 day by used) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (Administered the vaccine to 346 patients after the 30 day by used) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Patient administered the vaccine after the 30 days by used) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 04-Jun-2022 and administered vaccine on 12-JUL-2022).    Concomitant medications were not reported.  Patient received half dose. They administered the vaccine to 346 patients after the 30 days by used and total Number of vials was 35. The vial did not undergo any temperature excursions. Treatment medications were not reported.
Pt c/o achiness for 2-4 days site was swollen with a red rash in the shape of a T (inverted) got worse for 4 days - faded after 7 days.
On 08/06/2022, I woke up with a terrible runny nose and a bad cough. I had a low-grade fever and chills. I immediately tested myself for COVID-19 and then again in a few hours. I was positive both times. I was actually positive for 10 days. After testing positive, I called my doctor who prescribed Paxlovid. After 2 doses of the Paxlovid, I already felt like I was better. I finished up the medication. After I was testing negative, I was experiencing severe nausea and I lost my voice. The doctor's office told me to increase my allergy medication which seemed to help clear up my cough.
Had a sore arm day after vaccine for about 2 days. Had extreme fatigue on Sunday, Dec 19. From 12/20-12/23 had a very bad headache. Started on the left side of my head and then moved to the right side and down the side and back of my head to my neck. Developed rash in various places on arms and chest 12/20 and all over abdomen 12/22
Pain in arm and leg; Neck pain; Joint pain; Muscle pain; Pain at the injection site in shoulder; Felt uncomfortable; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (Pain in arm and leg), MALAISE (Felt uncomfortable), NECK PAIN (Neck pain), VACCINATION SITE PAIN (Pain at the injection site in shoulder) and ARTHRALGIA (Joint pain) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included DEXKETOPROFEN TROMETAMOL (DEXALGIN) for an unknown indication.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced MALAISE (Felt uncomfortable) and VACCINATION SITE PAIN (Pain at the injection site in shoulder). On 20-Jan-2021, the patient experienced NECK PAIN (Neck pain), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain). On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm and leg). The patient was treated with IBUPROFEN at an unspecified dose and frequency and CANNABIDIOL at an unspecified dose and frequency. On 18-Jan-2021, MALAISE (Felt uncomfortable) outcome was unknown. At the time of the report, PAIN IN EXTREMITY (Pain in arm and leg), NECK PAIN (Neck pain), VACCINATION SITE PAIN (Pain at the injection site in shoulder), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. On or about 30-SEP-2015, the patient was inoculated with ZOSTAVAX (lot number, dosage, and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to have extensive eye disorders and complications. The day after being administered ZOSTAVAX vaccine, the patient experienced pain and injection site redness and swelling, as well as pain in both of her eyes. On or about 01-OCT-2015, the patient began to experience further eye issues and sought treatment from physicians and was diagnosed with acute conjunctivitis in both eyes, multiple and a corneal ulcer attributable to the ZOSTAVAX vaccine. Between the dates of 12-FEB-2016 and 27-OCT-2016, the patient underwent twelve additional medical encounters and was treated for multiple chalazions in both eyes, peripheral ulcers, severe eye pain and further complications with her vision resulting from her ZOSTAVAX vaccine. The patient has been prescribed ofloxacin ophthalmic solution, gentamicin sulfate ophthalmic, PENLAC, MAXITROL drops and ointment, and 'besbiance' for management of her painful ocular symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Upon internal review, corneal ulcer was determined a significant medical event. Additional information has been requested.
My daughter start with up normal diarrhea yellow liquid color and rolling her eyes then she start twitched her hand and eyes then she got seizure and brain injury that is make disability for her development until now they destroyed all my family life.
I contracted COVID. On July 13 I tested positive. I was coughing and my head felt swollen. When I woke up I had a runny nose, severe congestion. No fever. I called the doctor and did a video and they gave me PAXLOVID. I still have hoarseness in the throat, my nose is still runny, and I still have a cough. It has been a week. I did have a chronic headache lasting about 3 days. I lost my sense of taste and smell for about 3 to 4 days, from July 14th to the 18th. I was very tired and fatigued, and I had moments of brain fog.
inconsolable crying for 6 hrs p/vax; no reddness swelling @ site; no discomfort; no problems w/taking bottle; seen by family MD 21DEC93;
got first shot and got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient never had chicken pox, all of his/her 5 kids did and he/she worked in a daycare that had a chicken pox out break.  The patient  got the first shot and got shingles for the third time, once after the first shot since he/she got the second shot he/she haven't had them again.
I have had blurry vision since around 12pm on the 23rd. Today is slightly worse.
This spontaneous report was received from a medical assistant referring to a multiple unspecified patients. There was no information about the patients' concurrent conditions and medical history provided. The patients' concomitant medication included sterile diluent (MERCK) which was properly stored. On an unspecified date in December 2017, the patients' were vaccinated with an improperly stored dose of VARIVAX (dosage, frequency and route of administration were not reported), lot#: N025933 (expiration date: 19-SEP-2019), lot#: N020686 (expiration date: 27-JUL-2019,) lot # N014630 (expiration date: 11-AUG-2019 "also reported on 11-MAY-2019", for prophylaxis. The administered dose of the vaccine experienced a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit (10.6 F) for 15 hours, as recorded by a data logger. The vaccines had not had any previous temperature excursions. There was no adverse effect reported. Sender's Comments: US-009507513-1802USA008842: US-009507513-1802USA008838: US-009507513-1802USA008839: US-009507513-1802USA008840: US-009507513-1802USA008841: US-009507513-1802USA008836: US-009507513-1801USA014257: US-009507513-1802USA008837.
VAXELIS administered since temperature excursion above 8.5° (10 mins)/Previous temperature excursion on 12-APR-22 above 8°C (10 mins); This non-serious spontaneous report was received by partner (reference number 02197725) on 05-JUL-2022 and forwarded on 06-JUL-2022 from a consumer.    The causal relationship between Vaxelis and the reported event "multiple doses of VAXELIS administered since temperature excursion" was assessed as not applicable due to the nature of the event.    Further information is expected.  FOLLOW-UP INFORMATION was received by a partner on 01-AUG-2022 and forwarded on 03-AUG-2022, from a HCP. The case is maintained as non-serious.  The reporter confirmed that there were no Adverse Events following Vaxelis administration to the patient.  Due to the nature of the event, the causality between the event "VAXELIS administered since temperature excursion above 8.5° (10 mins)/Previous temperature excursion on 12-APR-22 above 8°C (10 mins)" and Vaxelis remained not applicable.  For reference purposes this case is linked to MCM-003724, MCM-003725, MCM-003726, MCM-003729, MCM-003734, MCM-003735, MCM-003737, MCM-003738, MCM-003739, MCM-003740, MCM-003741, MCM-003742, MCM-003743, MCM-003744, MCM-003747, MCM-003749, MCM-003751, MCM-003752, MCM-003753, MCM-003759, MCM-003760, MCM-003761, MCM-003763, MCM-003766, MCM-003767, MCM-003769, MCM-003770, and MCM-003772, due to same reporter.  No further information is expected.
a patient that received the second dose of moderna vaccine after 10 days of getting the first shot; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (a patient that received the second dose of moderna vaccine after 10 days of getting the first shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (a patient that received the second dose of moderna vaccine after 10 days of getting the first shot). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (a patient that received the second dose of moderna vaccine after 10 days of getting the first shot) had resolved.            Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.
This spontaneous case was reported by a pharmacist and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Received vaccine that underwent a temperature excursion in the freezer), PRODUCT TEMPERATURE EXCURSION ISSUE (Received vaccine that underwent a temperature excursion in the freezer) and NO ADVERSE EVENT (No adverse event) in a 53-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7147B) for COVID-19 prophylaxis.     No Medical History information was reported.          No Concomitant medications were provided.  Reporter reported that a temperature excursion that occurred several days ago in the Freezer.   Multiple patients received vaccine from vaccine that underwent a temperature excursion in the Freezer.   Prior to knowing that the vaccines which underwent a temperature excursion in the freezer were viable 131 patients received doses of the vaccine in question.  Patient did not reported any adverse event.  No treatment medications were provided.
pt recvd vax & w/in hrs of vax pt exp hives;An ER or MD visit was required;hives resolved spontaneously;
Patient fainted after receiving  first pfizer covid vaccination.  Fainting occurred approximately 1/2 hour after administration at the front registers of store. I did not witness the event. Patient was alert and seemed okay, although confused, when I arrived at the front of store.
pt recv vax 1OCT97 & was found to be pregnant by home pregnancy test;LMP 28FEB97;pt exp a spontaneous abortion @ 10wk of pregnant;pt was told by NP that eval the tissue @ miscarriage that there was no sign of fetal development in tissue;onl
Leg area of induration/erythema on left leg. Small cluster of vesicles in center of erythema. ? abscess/cellulitis vs. inset bite. Called office 07/07/02 by mom to report.
Profound fatigue and generalized soreness most severe on days 2 and 3 after vaccination, but lasting seven days.  No fever or chills.  Arm sore, warm and swollen, but not red.  It is the severity of the reaction and its duration that prompts this submission.
headache; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable consumer (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), via an unspecified route on 03Feb2021 (Batch/Lot number was not reported) as an unknown 1st, single dose for covid-19 immunization. No medical history or concomitant medications were reported. It was reported that the patient had a headache after the 1st dose on 03Feb2021. Wanted to know if she could take TYLENOL. The outcome of the event was unknown. Follow-up attempts are completed. No further information is expected. Information on the lot/batch number has been requested.
I had the first shot. I can't get the second due to a severe reaction; This case was reported by a consumer via interactive digital media and described the occurrence of incomplete course of vaccination in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingrix (received first dose on an unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The patient received the first dose and developed severe reaction. Due to this tilll the time of reporting, the patient did not receive second dose which led to incomplete course of vaccination.
Pt received vaccine 7/2/10 post C-section per CDC guidelines. Within 2 weeks has developed progressive neurologic deficit and weakness. She is now a patient in Neuro ICU.
(R) arm localized swelling, redness 8 x 7 cm no treatment given. Recommend TYLENOL/Advil for pain.
pt recvd vax 11SEP95 & devel raised rash around the inj site;rash did not resemble varciella;No further details were provided;
This spontaneous report was received from a office manager (also reported as healthcare worker) refers to patients of unknown age. On an unknown date between 17-FEB-2014 to 21-MAR-2014, the patients were vaccinated with a dose of PNEUMOVAX 23, (lot number, expiry date was not reported) which was improperly stored and no adverse effects were reported. This is one of the several reports received from the same reporter. Additional information has been requested.